Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Wegener's Granulomatosis: early-phase trial registry
1 of 8 indexed Wegener's Granulomatosis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 1 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Wegener's Granulomatosis: 8 US clinical trials tracked, 1 recruiting.
Wegener's Granulomatosis is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Allergy and Infectious Diseases (NIAID), running 4 of these trials.
Enrollment posture brief
Registry condition wegeners-granulomatosis
OPEN 1 | RECR 13% | LATE 1 | EARLY 6 | RANK #2176 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Acute Respiratory Infection (13% recruiting · 8 trials)
Wegener's Granulomatosis lists 1 open slots (13% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Wegener's Granulomatosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Wegener's Granulomatosis is recruiting below its size-band peers.
1 of 8 indexed trials (12.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Wegener's Granulomatosis research.
National Institute of Allergy and Infectious Diseases (NIAID) accounts for 4 of 8 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Wegener's Granulomatosis trials plan to enrol fewer than 100 people.
Median target enrolment is 65 among the 8 trials that report a genuine target (sentinel values excluded). 6 of those (75%) plan for fewer than 100 participants.
-
Wegener's Granulomatosis research is mostly interventional.
7 interventional and 1 observational studies make up this index (87.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Vasculitis Pregnancy Registry
University of Pennsylvania
NCT02593565
Etanercept for Wegener's Granulomatosis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT00005007
Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00004567
Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
University of South Florida
NCT02108860
Etanercept to Treat Wegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001901
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
University of Pennsylvania
NCT00468208
Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001761
An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00072592
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 3 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Wegener's Granulomatosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Wegener's Granulomatosis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Wegener's Granulomatosis page
8 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Wegener's Granulomatosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Allergy and Infectious Diseases (NIAID) sponsors the most Wegener's Granulomatosis trials on record, review their full trial history before evaluating a specific study. See National Institute of Allergy and Infectious Diseases (NIAID)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Wegener's Granulomatosis condition card totals 8 registered trials; most-linked intervention Etanercept; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.